<DOC>
	<DOC>NCT00617045</DOC>
	<brief_summary>The purpose of this study is to assess whether the antidepressant, duloxetine, is equally effective as a treatment for subjects who have a Postpartum Onset Depression compared to subjects who have an onset of Major Depressive Disorder prior to delivery. The hypothesis is that duloxetine will be as effective in subjects with Postpartum Major Depressive Disorder as in subjects with a Major Depressive Disorder.</brief_summary>
	<brief_title>Duloxetine for the Treatment of Postpartum Depression</brief_title>
	<detailed_description>Study was terminated because of poor enrollment</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depressive Disorder, Major</mesh_term>
	<mesh_term>Depression, Postpartum</mesh_term>
	<mesh_term>Duloxetine Hydrochloride</mesh_term>
	<criteria>adult female subjects age 18 and above if onset of depression within 4 weeks of delivery,or onset of depression antenatally either during pregnancy or before pregnancy must score greater than or equal to 12 on the Edinburgh Postnatal Depression Scale speak English or Spanish have access to a telephone provide written and verbal consent have current or lifetime psychosis an unstable medical condition hypertension narrowangle glaucoma liver disease seizure disorders bulimia anorexia mania substance abuse disorders have a known hypersensitivity to duloxetine or any of the active ingredients are in need of inpatient hospital treatment with an excluded medication adolescents under the age of 18 Medication Exclusion other antidepressants antipsychotic agents quinolone antibiotics Type 1C antiarrhythmics daily benzodiazepines Treatment with a monoamine oxidase inhibitor</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Post Partum Depression</keyword>
</DOC>